The surveillance regarding the ultra-rapid insulin glulisine (Apidra).

Trial Profile

The surveillance regarding the ultra-rapid insulin glulisine (Apidra).

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Insulin glulisine (Primary)
  • Indications Diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 09 Aug 2013 Planned initiation date changed from 1 Apr 2012 to 1 Aug 2013 as reported by University Hospital Medical Information Network - Japan
    • 06 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top